The decision by the FDA to permit retail pharmacies to dispense medication abortion pills could remove barriers related to time, distance, and costs for patients in states with laws legalizing abortion care. One possible risk is a lawsuit filed by the Alliance for Hippocratic Medicine, an anti-abortion group that claims the FDA did not approve mifepristone with sufficient scientific evidence.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content